These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36882122)

  • 121. PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies.
    Mercanti L; Sindaco M; Mazzone M; Di Marcantonio MC; Piscione M; Muraro R; Mincione G
    Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296886
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Golgi's Role in the Development of Possible New Therapies in Cancer.
    Vlad DB; Dumitrascu DI; Dumitrascu AL
    Cells; 2023 May; 12(11):. PubMed ID: 37296620
    [TBL] [Abstract][Full Text] [Related]  

  • 123. p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act.
    Guo Y; Tang Y; Lu G; Gu J
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242146
    [TBL] [Abstract][Full Text] [Related]  

  • 124. ABCB1 and ABCC1 Function during TGF-β-Induced Epithelial-Mesenchymal Transition: Relationship between Multidrug Resistance and Tumor Progression.
    da Costa KM; Freire-de-Lima L; da Fonseca LM; Previato JO; Mendonça-Previato L; Valente RDC
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047018
    [TBL] [Abstract][Full Text] [Related]  

  • 125. An alpha-N-acetylgalactosaminylation at the threonine residue of a defined peptide sequence creates the oncofetal peptide epitope in human fibronectin.
    Matsuura H; Greene T; Hakomori S
    J Biol Chem; 1989 Jun; 264(18):10472-6. PubMed ID: 2471705
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.
    Freire-de-Lima L; Gelfenbeyn K; Ding Y; Mandel U; Clausen H; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17690-5. PubMed ID: 22006308
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K; Cerny RL; Tanouchi A; Kohno K; Kotani N; Honke K; Saibara T; Hollingsworth MA
    Oncogene; 2011 Dec; 30(49):4843-54. PubMed ID: 21625220
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.
    Bennett EP; Hassan H; Mandel U; Hollingsworth MA; Akisawa N; Ikematsu Y; Merkx G; van Kessel AG; Olofsson S; Clausen H
    J Biol Chem; 1999 Sep; 274(36):25362-70. PubMed ID: 10464263
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
    Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
    Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
    [TBL] [Abstract][Full Text] [Related]  

  • 130. UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.
    Banford S; Timson DJ
    Curr Cancer Drug Targets; 2017; 17(1):53-61. PubMed ID: 27659430
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation.
    Sanz-Martinez I; Pereira S; Merino P; Corzana F; Hurtado-Guerrero R
    Acc Chem Res; 2023 Mar; 56(5):548-560. PubMed ID: 36815693
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Sweet and sour: the impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition.
    Freire-de-Lima L
    Front Oncol; 2014; 4():59. PubMed ID: 24724053
    [TBL] [Abstract][Full Text] [Related]  

  • 133.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 134.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.